The market session has come to an end, and the closing bell has rung... so now it is time to go through today's biggest movers to the upside. Here are 6 of the biggest marijuana stock winners in trading on Tuesday, September 12th, 2017.
OTC-listed shares of Aphria Inc. rose 5.67% on roughly 2x average daily trading volume, closing the day at $5.24 per share.
Axim Biotechnologies, Inc. (OTC:AXIM)
Shares of Axim Biotechnologies, Inc. rose 9.34% on lower than average daily trading volume, closing the day at $6.67 per share.
Cronos Group, Inc. (OTC:PRMCF)
OTC-listed shares of Cronos Group, Inc. rose 3.91% today on higher than average trading volume, closing the day at $1.9011 per share. This bullish action comes on the heels of today's announcement that the company has received "Nasdaq International Designation"..
Shares of Heliospectra AB rose 10.35% today on higher than average trading volume, closing the day at $0.5297 per share.
India Globalization Capital, Inc. (NYSE:IGC)
Shares of India Globalization Capital, Inc. rose 5.38% on almost 2x average daily trading volume, closing the day at $0.3582 per share.
Invictus MD Strategies Corp. (OTC:IVITF)
OTC-listed shares of Invictus MD Strategies Corp. rose 6.34% on slightly lower than average daily trading volume, closing the day at $0.9624 per share.
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
